Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression
- PMID: 16452185
- DOI: 10.1158/0008-5472.CAN-05-3060
Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression
Abstract
The cytokines of transforming growth factor beta (TGF-beta) and its superfamily members are potent regulators of tumorigenesis and multiple cellular events. Myostatin is a member of TGF-beta superfamily and plays a negative role in the control of cell proliferation and differentiation. We now show that myostatin rapidly activated the extracellular signal-regulated kinase 1/2 (Erk1/2) cascade in C2C12 myoblasts. A more remarkable Erk1/2 activation stimulated by myostatin was observed in differentiating cells than proliferating cells. The results also showed that Ras was the upstream regulator and participated in myostatin-induced Erk1/2 activation because the expression of a dominant-negative Ras prevented myostatin-mediated inhibition of Erk1/2 activation and proliferation. Importantly, the myostatin-suppressed myotube fusion and differentiation marker gene expression were attenuated by blockade of Erk1/2 mitogen-activated protein kinase (MAPK) pathway through pretreatment with MAPK/Erk kinase 1 (MEK1) inhibitor PD98059, indicating that myostatin-stimulated activation of Erk1/2 negatively regulates myogenic differentiation. Activin receptor type IIb (ActRIIb) was previously suggested as the only type II membrane receptor triggering myostatin signaling. In this study, by using synthesized small interfering RNAs and dominant-negative ActRIIb, we show that myostatin failed to stimulate Erk1/2 phosphorylation and could not inhibit myoblast differentiation in ActRIIb-knockdown C2C12 cells, indicating that ActRIIb was required for myostatin-stimulated differentiation suppression. Altogether, our findings in this report provide the first evidence to reveal functional role of the Erk1/2 MAPK pathway in myostatin action as a negative regulator of muscle cell growth.
Similar articles
-
Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells.Cell Signal. 2007 Nov;19(11):2286-95. doi: 10.1016/j.cellsig.2007.07.002. Epub 2007 Aug 8. Cell Signal. 2007. PMID: 17689926
-
Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.J Cell Biochem. 2007 Aug 1;101(5):1266-77. doi: 10.1002/jcb.21249. J Cell Biochem. 2007. PMID: 17265428
-
Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in inhibition of myogenic differentiation of myoblasts by hypoxia.Exp Physiol. 2012 Feb;97(2):257-64. doi: 10.1113/expphysiol.2011.061382. Epub 2011 Oct 14. Exp Physiol. 2012. PMID: 22002869
-
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.Oncogene. 2007 May 14;26(22):3227-39. doi: 10.1038/sj.onc.1210414. Oncogene. 2007. PMID: 17496918 Review.
-
Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes.Biochem Cell Biol. 2004 Dec;82(6):603-9. doi: 10.1139/o04-110. Biochem Cell Biol. 2004. PMID: 15674427 Review.
Cited by
-
ERK1/2 inhibition promotes robust myotube growth via CaMKII activation resulting in myoblast-to-myotube fusion.Dev Cell. 2021 Dec 20;56(24):3349-3363.e6. doi: 10.1016/j.devcel.2021.11.022. Dev Cell. 2021. PMID: 34932950 Free PMC article.
-
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs.Endocr Rev. 2022 Mar 9;43(2):329-365. doi: 10.1210/endrev/bnab030. Endocr Rev. 2022. PMID: 34520530 Free PMC article. Review.
-
Myostatin Promotes Interleukin-1β Expression in Rheumatoid Arthritis Synovial Fibroblasts through Inhibition of miR-21-5p.Front Immunol. 2017 Dec 8;8:1747. doi: 10.3389/fimmu.2017.01747. eCollection 2017. Front Immunol. 2017. PMID: 29276516 Free PMC article.
-
GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration.Cell Metab. 2015 Jul 7;22(1):164-74. doi: 10.1016/j.cmet.2015.05.010. Epub 2015 May 19. Cell Metab. 2015. PMID: 26001423 Free PMC article.
-
Myostatin in the pathophysiology of skeletal muscle.Curr Genomics. 2007 Nov;8(7):415-22. doi: 10.2174/138920207783591672. Curr Genomics. 2007. PMID: 19412331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous